Kamel Masmoudi

1.3k total citations
57 papers, 791 citations indexed

About

Kamel Masmoudi is a scholar working on Pharmacology, Neurology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Kamel Masmoudi has authored 57 papers receiving a total of 791 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 10 papers in Neurology and 10 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Kamel Masmoudi's work include Pharmacological Effects and Toxicity Studies (10 papers), Pharmacovigilance and Adverse Drug Reactions (7 papers) and Drug-Induced Adverse Reactions (6 papers). Kamel Masmoudi is often cited by papers focused on Pharmacological Effects and Toxicity Studies (10 papers), Pharmacovigilance and Adverse Drug Reactions (7 papers) and Drug-Induced Adverse Reactions (6 papers). Kamel Masmoudi collaborates with scholars based in France, United States and Belgium. Kamel Masmoudi's co-authors include Sophie Liabeuf, Valérie Gras‐Champel, Benjamin Batteux, Michel Andréjak, Youssef Bennis, Henri Masson, Gabriel Choukroun, Valérie Gras, Sandra Bodeau and Anne‐Sophie Lemaire‐Hurtel and has published in prestigious journals such as Neurology, Brain Research and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Kamel Masmoudi

55 papers receiving 776 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kamel Masmoudi France 18 139 116 105 102 91 57 791
Jamie N. Brown United States 19 50 0.4× 94 0.8× 63 0.6× 76 0.7× 54 0.6× 69 911
Tess E Cooper Australia 17 183 1.3× 79 0.7× 59 0.6× 65 0.6× 339 3.7× 41 945
Guan J Liu China 20 70 0.5× 66 0.6× 88 0.8× 127 1.2× 21 0.2× 39 1.1k
Min Kyung Hyun South Korea 17 43 0.3× 104 0.9× 51 0.5× 116 1.1× 63 0.7× 64 976
Tiziana Ciarambino Italy 19 42 0.3× 100 0.9× 117 1.1× 127 1.2× 34 0.4× 65 945
Yan Jiang China 18 43 0.3× 101 0.9× 33 0.3× 157 1.5× 67 0.7× 106 1.1k
Elizabeth Silaid Muxfeldt Brazil 25 56 0.4× 122 1.1× 97 0.9× 84 0.8× 25 0.3× 67 2.1k
Jian Ying United States 18 58 0.4× 39 0.3× 211 2.0× 120 1.2× 37 0.4× 55 1.1k
Jennifer Donnan Canada 15 130 0.9× 31 0.3× 32 0.3× 128 1.3× 123 1.4× 44 714
Christiano Argano Italy 19 43 0.3× 55 0.5× 83 0.8× 357 3.5× 33 0.4× 62 1.3k

Countries citing papers authored by Kamel Masmoudi

Since Specialization
Citations

This map shows the geographic impact of Kamel Masmoudi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kamel Masmoudi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kamel Masmoudi more than expected).

Fields of papers citing papers by Kamel Masmoudi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kamel Masmoudi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kamel Masmoudi. The network helps show where Kamel Masmoudi may publish in the future.

Co-authorship network of co-authors of Kamel Masmoudi

This figure shows the co-authorship network connecting the top 25 collaborators of Kamel Masmoudi. A scholar is included among the top collaborators of Kamel Masmoudi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kamel Masmoudi. Kamel Masmoudi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lebrun-Vignes, Bénédicte, Kamel Masmoudi, Thierry Vial, et al.. (2025). Vaccines and the risk of Guillain-Barré syndrome: A French pharmacovigilance analysis. Therapies. 80(5). 580–588. 1 indexed citations
2.
Laville, Solène M., Sophie Liabeuf, Benjamin Batteux, et al.. (2024). Medication-overuse headache: A pharmacovigilance study in France. Therapies. 79(5). 565–575. 1 indexed citations
3.
Liabeuf, Sophie, Youssef Bennis, Solène M. Laville, et al.. (2023). Statin therapy and the incidence of atherosclerotic cardiovascular events after kidney transplantation. Nephrology Dialysis Transplantation. 39(5). 818–829. 1 indexed citations
4.
Massy, Nathalie, et al.. (2023). COVID-19 et vaccins à adénovirus : expérience française de suivi renforcé de pharmacovigilance. Therapies. 78(5). 489–498. 1 indexed citations
5.
Auffret, Marine, et al.. (2022). Guillain–Barré Syndrome Associated with COVID-19 Vaccines: A Perspective From Spontaneous Report Data. Clinical Drug Investigation. 42(7). 581–592. 14 indexed citations
6.
Gras, Valérie, et al.. (2022). Use of the Capture-Recapture Method to Estimate the Frequency of Community- and Hospital-Acquired Drug-Induced Acute Kidney Injuries in French Databases. Frontiers in Pharmacology. 13. 899164–899164. 4 indexed citations
7.
8.
Delaunay, Pascal, et al.. (2021). Impact of the COVID-19 outbreak on the reporting of adverse drug reactions associated with self-medication. Annales Pharmaceutiques Françaises. 79(5). 522–529. 21 indexed citations
9.
Chaby, G., Sophie Liabeuf, Valérie Gras‐Champel, et al.. (2021). Associations between dysbiosis-inducing drugs, overall survival and tumor response in patients treated with immune checkpoint inhibitors. Therapeutic Advances in Medical Oncology. 13. 4277412623–4277412623. 36 indexed citations
10.
Batteux, Benjamin, Sandra Bodeau, Valérie Gras‐Champel, et al.. (2020). Abnormal laboratory findings and plasma concentration monitoring of lopinavir and ritonavir in COVID‐19. British Journal of Clinical Pharmacology. 87(3). 1547–1553. 7 indexed citations
11.
Batteux, Benjamin, et al.. (2019). Ischaemic colitis associated with intravitreal administration of aflibercept: A first case report. British Journal of Clinical Pharmacology. 85(4). 845–848. 4 indexed citations
12.
Rousseau, Vanessa, Delphine Abadie, Kamel Masmoudi, et al.. (2017). Effets indésirables « graves » du tramadol : bilan 2011–2015 de pharmacovigilance en France. Therapies. 72(6). 615–624. 22 indexed citations
13.
Gras, Valérie, Joëlle Micallef, Sylvie Picard, et al.. (2016). The drugs that mostly frequently induce acute kidney injury: a case − noncase study of a pharmacovigilance database. British Journal of Clinical Pharmacology. 83(6). 1341–1349. 85 indexed citations
14.
Gras, Valérie, et al.. (2016). Syndrome de sevrage aux benzodiazépines ou apparentés au cours d’une hospitalisation, à propos de 22 cas. Therapies. 71(3). 323–328. 1 indexed citations
15.
Liabeuf, Sophie, et al.. (2016). Adaptation and validation of an adverse drug reaction preventability score for bleeding due to vitamin K antagonists. Medicine. 95(39). e4762–e4762. 1 indexed citations
16.
Liabeuf, Sophie, et al.. (2015). Risk Factors for Bleeding in Hospitalized at Risk Patients With an INR of 5 or More Treated With Vitamin K Antagonists. Medicine. 94(52). e2366–e2366. 11 indexed citations
17.
Gras‐Champel, Valérie, et al.. (2010). Évaluation de l’évitabilité des accidents hémorragiques sous antivitamines K. Therapies. 65(3). 261–268. 5 indexed citations
18.
Lemaire‐Hurtel, Anne‐Sophie, et al.. (2008). Les recommandations d’adaptation posologique à la fonction rénale ne sont pas toujours suffisantes pour éviter la neurotoxicité des bêtalactamines. Néphrologie & Thérapeutique. 5(2). 144–148. 9 indexed citations
19.
Masmoudi, Kamel, Nicole Larnicol, Fabrice Wallois, & F Gros. (1997). Changes in Fos-like immunoreactivity evoked by maturation of the sneeze reflex triggered by nasal air puff stimulation in kittens. Brain Research. 757(1). 102–110. 10 indexed citations
20.
Wallois, Fabrice, F Gros, Kamel Masmoudi, & Nicole Larnicol. (1995). C-Fos-like immunoreactivity in the cat brainstem evoked by sneeze-inducing air puff stimulation of the nasal mucosa. Brain Research. 687(1-2). 143–154. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jamie N. Brown Breakdown of academic impact, for papers by Tess E Cooper Breakdown of academic impact, for papers by Guan J Liu Breakdown of academic impact, for papers by Min Kyung Hyun Breakdown of academic impact, for papers by Tiziana Ciarambino Breakdown of academic impact, for papers by Yan Jiang Breakdown of academic impact, for papers by Elizabeth Silaid Muxfeldt Breakdown of academic impact, for papers by Jian Ying Breakdown of academic impact, for papers by Jennifer Donnan Breakdown of academic impact, for papers by Christiano Argano
Rankless by CCL
2026